Anne Kirby
Plus aucun poste en cours
Fortune : - $ au 30/09/2023
Historique de carrière de Anne Kirby
Anciens postes connus de Anne Kirby
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| REGNUM CORP. | Directeur/Membre du Conseil | 07/04/2021 | 23/05/2023 |
| Directeur Général | 07/04/2021 | 23/05/2023 | |
| President | 07/04/2021 | 23/05/2023 | |
| Secrétaire Général | 07/04/2021 | 23/05/2023 | |
Vyera Pharmaceuticals LLC
 Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/10/2018 | 01/04/2021 |
Formation de Anne Kirby
| University of Akron | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 3 |
| 2 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Vyera Pharmaceuticals LLC
Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Health Technology |
| Regnum Corp. |
- Bourse
- Insiders
- Anne Kirby
- Expérience
